Forte Biosciences Inc banner

Forte Biosciences Inc
NASDAQ:FBRX

Watchlist Manager
Forte Biosciences Inc Logo
Forte Biosciences Inc
NASDAQ:FBRX
Watchlist
Price: 26.74 USD -1.4% Market Closed
Market Cap: $335.1m

During the last 3 months Forte Biosciences Inc insiders bought 254.8k USD , and have not sold any shares. The stock price has increased by 22% over this period (open performance analysis).

The last transaction was made on Dec 30, 2025 by Riley Antony A , who bought 254.8k USD worth of FBRX shares.

Last Transactions:
Riley Antony A
$+254.8k
Riley Antony A
$+125k
Wagner Paul A.
$+301
Wagner Paul A.
$+288
Wagner Paul A.
$+294.2
Wagner Paul A.
$+123.5
Wagner Paul A.
$+647.5
Wagner Paul A.
$+372
Wagner Paul A.
$+846.6
Wagner Paul A.
$+6.9
Wagner Paul A.
$+93.3
Wagner Paul A.
$+1.9k
Wagner Paul A.
$+2.3k
Riley Antony A
$-3.6k
Wagner Paul A.
$-173.9k
Riley Antony A
$+1.1k
Riley Antony A
$+2.7k
Wagner Paul A.
$+4.1k
Oliveira Steven Michael
$+235.6
Oliveira Steven Michael
$+234.4
Hasnain Faheem
$+477.5
Duvall Martin J
$+56.4
Foletta Mark G
$+55.8
Gruber Harry E
$+59.2
Das Asha
$+70
Hasnain Faheem
$+2.7k
Schimmel Paul
$+270
Foletta Mark G
$+130
Gruber Harry E
$+670
View All Transactions

During the last 3 months Forte Biosciences Inc insiders bought 254.8k USD , and have not sold any shares. The stock price has increased by 22% over this period (open performance analysis).

The last transaction was made on Dec 30, 2025 by Riley Antony A , who bought 254.8k USD worth of FBRX shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
1
254.8k USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Forte Biosciences Inc
Insider Trading Chart

Forte Biosciences Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Forte Biosciences Inc
Last Insider Transactions

Global
Insiders Monitor

Forte Biosciences Inc
Glance View

Market Cap
335.1m USD
Industry
Biotechnology

Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The company is headquartered in Torrance, California and currently employs 5 full-time employees. The company went IPO on 2017-04-13. The firm is focused on its lead product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis (AD). FB401 was developed in collaboration with the National Institutes of Health (NIH), and the National Institute of Allergy and Infectious Diseases (NIAID). FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.

FBRX Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett